AVA-101

Shares of Avalanche Biotechnologies Inc (NASDAQ: AAVL) closed up more than 7 percent on Wednesday following positive commentary by TheStreet.com. According to author Alfredo Fontanini, the company is approaching an important clinical trial catalyst. Results from a phase IIa study of Avalanche's...